|
|
慢性硬膜下血肿形成及复发机制的研究进展
|
Abstract:
慢性硬膜下血肿(chronic subdural hematoma, cSDH)是常见的神经外科疾病，多见于老年人。血肿的进展原因、转化为慢性的过程有其复杂的病理生理机制，并与治疗效果息息相关。目前，慢性硬膜下血肿的主要治疗方法是钻孔引流术，但存在需要再次手术的复发风险，目前术后复发率约9%~37%。目前所认为的血肿复发的主要原因主要是钻孔术后血肿包膜依旧存在，血肿形成的病理生理机制并未被阻断。为降低术后复发率，目前对潜在病理生理学机制的理解已用于新的治疗方法——脑膜中动脉栓塞术(middle meningeal artery embolization, MMAE)。还需要大量研究以确定脑膜中动脉栓塞术是否能成功停止血肿进展过程，从而控制和缓解cSDH。本文就cSDH发生发展过程中的血管生成、炎症反应、纤溶亢进等关键过程以及cSDH复发机制和降低复发率的手术方式进行综述。
Chronic subdural hematoma (cSDH) is a common neurosurgical disease, mostly seen in the elderly. The progressive, chronic course of the disease has its own complex pathophysiological mechanisms and is closely related to the outcome of treatment. Currently, the main treatment for chronic subdural hematomas is drilling and drainage, but there is a risk of recurrence requiring reoperation, with current recurrence rates of approximately 9%~37%. The main reason for hematoma recurrence is that the hematoma envelope remains after drilling, and the pathophysiological mechanism of hematoma formation has not been blocked. To reduce the rate of postoperative recurrence, an understanding of the underlying pathophysiological mechanisms has been used in a new therapeutic approach, middle meningeal artery embolization (MMAE). Numerous studies are needed to determine whether MMAE is successful in stopping the process of hematoma generation and thus controlling and alleviating cSDH. This article provides a review of the key processes of angiogenesis, inflammatory response, and hyperfibrinolysis in the development of cSDH, as well as the mechanisms of recurrence of cSDH and new surgical approaches to reduce the recurrence rate.
| [1] | Kan, P., Maragkos, G.A., Srivatsan, A., Srinivasan, V., Johnson, J., Burkhardt, J., et al. (2020) Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Multi-Center Experience of 154 Consecutive Embolizations. Neurosurgery, 88, 268-277. https://doi.org/10.1093/neuros/nyaa379 |
| [2] | Kim, J., Moon, J., Kim, T., Ahn, S., Hwang, G., Bang, J., et al. (2015) Risk Factor Analysis for the Recurrence of Chronic Subdural Hematoma: A Review of 368 Consecutive Surgical Cases. Korean Journal of Neurotrauma, 11, 63-69. https://doi.org/10.13004/kjnt.2015.11.2.63 |
| [3] | Mori, K. and Maeda, M. (2001) Surgical Treatment of Chronic Subdural Hematoma in 500 Consecutive Cases: Clinical Characteristics, Surgical Outcome, Complications, and Recurrence Rate. Neurologia Medico-Chirurgica, 41, 371-381. https://doi.org/10.2176/nmc.41.371 |
| [4] | Balser, D., Farooq, S., Mehmood, T., Reyes, M. and Samadani, U. (2015) Actual and Projected Incidence Rates for Chronic Subdural Hematomas in United States Veterans Administration and Civilian Populations. Journal of Neurosurgery, 123, 1209-1215. https://doi.org/10.3171/2014.9.jns141550 |
| [5] | Yamamoto, H., Hirashima, Y., Hamada, H., Hayashi, N., Origasa, H. and Endo, S. (2003) Independent Predictors of Recurrence of Chronic Subdural Hematoma: Results of Multivariate Analysis Performed Using a Logistic Regression Model. Journal of Neurosurgery, 98, 1217-1221. https://doi.org/10.3171/jns.2003.98.6.1217 |
| [6] | Sim, Y., Min, K., Lee, M., Kim, Y. and Kim, D. (2012) Recent Changes in Risk Factors of Chronic Subdural Hematoma. Journal of Korean Neurosurgical Society, 52, 234-239. https://doi.org/10.3340/jkns.2012.52.3.234 |
| [7] | Debs, L.H., Walker, S.E. and Rahimi, S.Y. (2024) Newer Treatment Paradigm Improves Outcomes in the Most Common Neurosurgical Disease of the Elderly: A Literature Review of Middle Meningeal Artery Embolization for Chronic Subdural Hematoma. GeroScience, 46, 6537-6561. https://doi.org/10.1007/s11357-024-01173-5 |
| [8] | Han, M., Ryu, J.I., Kim, C.H., Kim, J.M., Cheong, J.H. and Yi, H. (2017) Predictive Factors for Recurrence and Clinical Outcomes in Patients with Chronic Subdural Hematoma. Journal of Neurosurgery, 127, 1117-1125. https://doi.org/10.3171/2016.8.jns16867 |
| [9] | Lee, K.-S. (2004) Reviewnatural History of Chronic Subdural Haematoma. Brain Injury, 18, 351-358. https://doi.org/10.1080/02699050310001645801 |
| [10] | Iliescu, I.A. and Constantinescu, A.I. (2015) Clinical Evolutional Aspects of Chronic Subdural Haematomas—Literature Review. Journal of Medicine and Life, 8, 26-33. |
| [11] | Lega, B.C., Danish, S.F., Malhotra, N.R., Sonnad, S.S. and Stein, S.C. (2010) Choosing the Best Operation for Chronic Subdural Hematoma: A Decision Analysis. Journal of Neurosurgery, 113, 615-621. https://doi.org/10.3171/2009.9.jns08825 |
| [12] | Sajanti, J. (2003) High Concentrations of Procollagen Propeptides in Chronic Subdural Haematoma and Effusion. Journal of Neurology, Neurosurgery & Psychiatry, 74, 522-524. https://doi.org/10.1136/jnnp.74.4.522 |
| [13] | Heula, A., Sajanti, J. and Majamaa, K. (2009) Procollagen Propeptides in Chronic Subdural Hematoma Reveal Sustained Dural Collagen Synthesis after Head Injury. Journal of Neurology, 256, 66-71. https://doi.org/10.1007/s00415-009-0048-6 |
| [14] | Osuka, K., Watanabe, Y., Usuda, N., Aoyama, M., Takeuchi, M. and Takayasu, M. (2014) Eotaxin-3 Activates the Smad Pathway through the Transforming Growth Factor Beta 1 in Chronic Subdural Hematoma Outer Membranes. Journal of Neurotrauma, 31, 1451-1456. https://doi.org/10.1089/neu.2013.3195 |
| [15] | Hong, H., Kim, Y., Yi, H., Ko, Y., Oh, S. and Kim, J. (2009) Role of Angiogenic Growth Factors and Inflammatory Cytokine on Recurrence of Chronic Subdural Hematoma. Surgical Neurology, 71, 161-165. https://doi.org/10.1016/j.surneu.2008.01.023 |
| [16] | Hara, M., Tamaki, M., Aoyagi, M., et al. (2009) Possible Role of Cyclooxygenase-2 in Developing Chronic Subdural Hematoma. Journal of Medical and Dental Sciences, 56, 101-106. |
| [17] | Hohenstein, A., Erber, R., Schilling, L. and Weigel, R. (2005) Increased mRNA Expression of VEGF within the Hematoma and Imbalance of Angiopoietin-1 and-2 mRNA within the Neomembranes of Chronic Subdural Hematoma. Journal of Neurotrauma, 22, 518-528. https://doi.org/10.1089/neu.2005.22.518 |
| [18] | Hua, C., Zhao, G., Feng, Y., Yuan, H., Song, H. and Bie, L. (2016) Role of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor in the Development of Chronic Subdural Hematoma. Journal of Neurotrauma, 33, 65-70. https://doi.org/10.1089/neu.2014.3724 |
| [19] | Osuka, K., Watanabe, Y., Usuda, N., Atsuzawa, K., Aoyama, M., Niwa, A., et al. (2012) Activation of RAS/MEK/ERK Signaling in Chronic Subdural Hematoma Outer Membranes. Brain Research, 1489, 98-103. https://doi.org/10.1016/j.brainres.2012.10.013 |
| [20] | Burbridge, M.F. (2002) The Role of the Matrix Metalloproteinases during in Vitro Vessel Formation. Angiogenesis, 5, 215-226. https://doi.org/10.1023/a:1023889805133 |
| [21] | Nakagawa, T., Kodera, T. and Kubota, T. (2000) Expression of Matrix Metalloproteinases in the Chronic Subdural Haematoma Membrane. Acta Neurochirurgica, 142, 61-66. https://doi.org/10.1007/s007010050008 |
| [22] | Kitazono, M., Yokota, H., Satoh, H., Onda, H., Matsumoto, G., Fuse, A., et al. (2012) Measurement of Inflammatory Cytokines and Thrombomodulin in Chronic Subdural Hematoma. Neurologia Medico-Chirurgica, 52, 810-815. https://doi.org/10.2176/nmc.52.810 |
| [23] | Osuka, K., Watanabe, Y., Usuda, N., Atsuzawa, K., Shima, H., Takeuchi, M., et al. (2013) Activation of JAK-STAT3 Signaling Pathway in Chronic Subdural Hematoma Outer Membranes. Neuroscience Letters, 534, 166-170. https://doi.org/10.1016/j.neulet.2012.11.011 |
| [24] | Osuka, K., Watanabe, Y., Usuda, N., Aoyama, M., Kawaguchi, R., Watabe, T., et al. (2016) Activation of Signal Transducer and Activator of Transcription 3 in Endothelial Cells of Chronic Subdural Hematoma Outer Membranes. World Neurosurgery, 91, 376-382. https://doi.org/10.1016/j.wneu.2016.04.025 |
| [25] | Li, A., Varney, M.L., Valasek, J., Godfrey, M., Dave, B.J. and Singh, R.K. (2005) Autocrine Role of Interleukin-8 in Induction of Endothelial Cell Proliferation, Survival, Migration and MMP-2 Production and Angiogenesis. Angiogenesis, 8, 63-71. https://doi.org/10.1007/s10456-005-5208-4 |
| [26] | Frati, A., Salvati, M., Mainiero, F., Ippoliti, F., Rocchi, G., Raco, A., et al. (2004) Inflammation Markers and Risk Factors for Recurrence in 35 Patients with a Posttraumatic Chronic Subdural Hematoma: A Prospective Study. Journal of Neurosurgery, 100, 24-32. https://doi.org/10.3171/jns.2004.100.1.0024 |
| [27] | Edlmann, E., Giorgi-Coll, S., Whitfield, P.C., Carpenter, K.L.H. and Hutchinson, P.J. (2017) Pathophysiology of Chronic Subdural Haematoma: Inflammation, Angiogenesis and Implications for Pharmacotherapy. Journal of Neuroinflammation, 14, Article No. 108. https://doi.org/10.1186/s12974-017-0881-y |
| [28] | Katano, H., Kamiya, K., Mase, M., Tanikawa, M. and Yamada, K. (2006) Tissue Plasminogen Activator in Chronic Subdural Hematomas as a Predictor of Recurrence. Journal of Neurosurgery, 104, 79-84. https://doi.org/10.3171/jns.2006.104.1.79 |
| [29] | Nomura, S., Kashiwagi, S., Fujisawa, H., Ito, H. and Nakamura, K. (1994) Characterization of Local Hyperfibrinolysis in Chronic Subdural Hematomas by SDS-PAGE and Immunoblot. Journal of Neurosurgery, 81, 910-913. https://doi.org/10.3171/jns.1994.81.6.0910 |
| [30] | Liu, H., Yan, R., Xie, F. and Richard, S.A. (2022) Hematoma Cavity Separation and Neomembrane Thickness Are Potential Triggers of Recurrence of Chronic Subdural Hematoma. BMC Surgery, 22, Article No. 236. https://doi.org/10.1186/s12893-022-01687-9 |
| [31] | Liu, L., Cao, X., Ren, Y., Zhou, L. and Yang, C. (2019) Risk Factors for Recurrence of Chronic Subdural Hematoma: A Single Center Experience. World Neurosurgery, 132, e506-e513. https://doi.org/10.1016/j.wneu.2019.08.089 |
| [32] | Mandai, S., Sakurai, M. and Matsumoto, Y. (2000) Middle Meningeal Artery Embolization for Refractory Chronic Subdural Hematoma. Journal of Neurosurgery, 93, 686-688. https://doi.org/10.3171/jns.2000.93.4.0686 |
| [33] | Link, T.W., Boddu, S., Paine, S.M., Kamel, H. and Knopman, J. (2018) Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Series of 60 Cases. Neurosurgery, 85, 801-807. https://doi.org/10.1093/neuros/nyy521 |
| [34] | Tempaku, A., Yamauchi, S., Ikeda, H., Tsubota, N., Furukawa, H., Maeda, D., et al. (2015) Usefulness of Interventional Embolization of the Middle Meningeal Artery for Recurrent Chronic Subdural Hematoma: Five Cases and a Review of the Literature. Interventional Neuroradiology, 21, 366-371. https://doi.org/10.1177/1591019915583224 |
| [35] | Shotar, E., Meyblum, L., Premat, K., Lenck, S., Degos, V., Grand, T., et al. (2020) Middle Meningeal Artery Embolization Reduces the Post-Operative Recurrence Rate of At-Risk Chronic Subdural Hematoma. Journal of NeuroInterventional Surgery, 12, 1209-1213. https://doi.org/10.1136/neurintsurg-2020-016048 |
| [36] | Fiorella, D., Monteith, S.J., Hanel, R., Atchie, B., Boo, S., McTaggart, R.A., et al. (2024) Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2409845 |
| [37] | Martinez-Gutierrez, J.C., D’Amato, S.A., Zeineddine, H.A., Nahhas, M.I., Kole, M.J., Kim, H.W., et al. (2023) Middle Meningeal Artery Embolization of Septated Chronic Subdural Hematomas. Interventional Neuroradiology. https://doi.org/10.1177/15910199231184521 |
